Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
Choosing the Right Path: Personal Factors to Consider The optimal choice depends on your individual circumstances, including your overall health, lifestyle, personal preferences, tolerance for side effects, and insurance coverage
Regular monitoring, quick intervention, and lifestyle changes make all the difference
This includes: Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Dulaglutide (Trulicity) Liraglutide (Saxenda) Most prescribing information suggests discontinuing these medications at least 2 months before attempting conception due to potential fetal harm observed in animal studies, including: Growth restriction Delayed skeletal development Increased pregnancy loss There is limited human data, but the risk signals are sufficient to justify a cautious, prevention-first approach
These medications influence appetite and glucose control, and personalized nutritional strategies can enhance their effectiveness, manage side effects, and promote overall well-being